62606-02-4

Usage

Uses

Used in Pharmaceutical Industry:
Benzenamine, 3-methoxy-5-(methylsulfonyl)is used as an intermediate in the synthesis of pharmaceuticals for its ability to be incorporated into various drug molecules, contributing to the development of new medications.
Used in Agrochemical Industry:
Benzenamine, 3-methoxy-5-(methylsulfonyl)is used as an intermediate in the synthesis of agrochemicals, playing a role in the production of pesticides and other agricultural products to improve crop protection and yield.
Used in Dye and Pigment Manufacturing:
Benzenamine, 3-methoxy-5-(methylsulfonyl)is used in the manufacturing of dyes and pigments due to its chemical structure that can impart color to various materials, serving the textile, paint, and printing industries.
Used in Organic Compound Synthesis:
Benzenamine, 3-methoxy-5-(methylsulfonyl)is utilized in the synthesis of other organic compounds, expanding its applications in the chemical industry for creating a range of products with diverse uses.

Upstream product

• 62606-17-1 1-(methyloxy)-3-(methylsulfonyl)-5-nitrobenzene 
• 41085-53-4 1-methylsulfonyl-3,5-dinitro-benzene 

Downstream Products

• 62606-08-0 (3-Methanesulfonyl-5-methoxy-phenyl)-(2,4,6-trinitro-phenyl)-amine 
• 1186605-02-6 3-iodo-1-methanesulfonyl-5-methoxy-benzene 

Relevant academic research and scientific papers

INDAZOLYL-PYRIMIDINES AS KINASE INHIBITORS

Disclosed are compounds having the formula: or a salt thereof, wherein A, n, R1, R1A, and R2 are as defined herein, and methods of making and using the same.

PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS

Disclosed are compounds having the formula (I): wherein Z, n, R1, R1A, R3, R4, and R5 are as defined herein, and methods of making and using the same.

LEUKOTRIENE B4 INHIBITORS

Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, COPD

Pteridinone derivatives as PI3-kinases inhibitors

New compounds of formula 1 are provided which by virtue of their pharmaceutical activity as PI3-kinase modulators may be used in the therapeutic field for the treatment of inflammatory or allergic diseases. Examples of these include inflammatory and allergic respiratory complaints, inflammatory diseases of the gastro-intestinal tract and motor apparatus, inflammatory and allergic skin diseases, inflammatory eye diseases, diseases of the nasal mucosa, inflammatory or allergic conditions involving autoimmune reactions or inflammations of the kidney.